nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—PTGS1—ulcerative colitis	0.399	1	CbGaD
Ketobemidone—PTGS1—Olsalazine—ulcerative colitis	0.0822	0.142	CbGbCtD
Ketobemidone—PTGS1—Balsalazide—ulcerative colitis	0.0733	0.127	CbGbCtD
Ketobemidone—PTGS1—Mesalazine—ulcerative colitis	0.0586	0.102	CbGbCtD
Ketobemidone—PTGS1—Sulfasalazine—ulcerative colitis	0.0327	0.0567	CbGbCtD
Ketobemidone—CYP2B6—Nicotine—ulcerative colitis	0.0321	0.0556	CbGbCtD
Ketobemidone—CYP2B6—Cholecalciferol—ulcerative colitis	0.0288	0.0498	CbGbCtD
Ketobemidone—CYP2C8—Nicotine—ulcerative colitis	0.0243	0.0421	CbGbCtD
Ketobemidone—CYP3A4—Budesonide—ulcerative colitis	0.0226	0.0392	CbGbCtD
Ketobemidone—CYP2C8—Cholecalciferol—ulcerative colitis	0.0218	0.0378	CbGbCtD
Ketobemidone—CYP2C19—Nicotine—ulcerative colitis	0.0204	0.0353	CbGbCtD
Ketobemidone—CYP2C19—Cholecalciferol—ulcerative colitis	0.0183	0.0317	CbGbCtD
Ketobemidone—CYP2C9—Nicotine—ulcerative colitis	0.0169	0.0294	CbGbCtD
Ketobemidone—CYP2C9—Cholecalciferol—ulcerative colitis	0.0152	0.0263	CbGbCtD
Ketobemidone—CYP2C8—Hydrocortisone—ulcerative colitis	0.0152	0.0263	CbGbCtD
Ketobemidone—CYP2C19—Prednisone—ulcerative colitis	0.0127	0.022	CbGbCtD
Ketobemidone—CYP2B6—Dexamethasone—ulcerative colitis	0.0125	0.0216	CbGbCtD
Ketobemidone—CYP3A4—Methylprednisolone—ulcerative colitis	0.0101	0.0175	CbGbCtD
Ketobemidone—CYP3A4—Nicotine—ulcerative colitis	0.00985	0.0171	CbGbCtD
Ketobemidone—CYP2C8—Dexamethasone—ulcerative colitis	0.00943	0.0163	CbGbCtD
Ketobemidone—CYP3A4—Cholecalciferol—ulcerative colitis	0.00884	0.0153	CbGbCtD
Ketobemidone—CYP2C19—Dexamethasone—ulcerative colitis	0.00791	0.0137	CbGbCtD
Ketobemidone—CYP3A4—Triamcinolone—ulcerative colitis	0.00766	0.0133	CbGbCtD
Ketobemidone—CYP2C9—Dexamethasone—ulcerative colitis	0.00658	0.0114	CbGbCtD
Ketobemidone—CYP3A4—Betamethasone—ulcerative colitis	0.00658	0.0114	CbGbCtD
Ketobemidone—CYP3A4—Prednisolone—ulcerative colitis	0.00649	0.0112	CbGbCtD
Ketobemidone—CYP3A4—Hydrocortisone—ulcerative colitis	0.00615	0.0107	CbGbCtD
Ketobemidone—CYP3A4—Prednisone—ulcerative colitis	0.00613	0.0106	CbGbCtD
Ketobemidone—CYP3A4—Dexamethasone—ulcerative colitis	0.00382	0.00663	CbGbCtD
Ketobemidone—OPRM1—GPCR ligand binding—PTGER4—ulcerative colitis	4.29e-05	0.00181	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	4.27e-05	0.0018	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	4.24e-05	0.00179	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—GNA12—ulcerative colitis	4.17e-05	0.00175	CbGpPWpGaD
Ketobemidone—OPRM1—TCR Signaling Pathway—TGFB1—ulcerative colitis	4.16e-05	0.00175	CbGpPWpGaD
Ketobemidone—OPRD1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	4.15e-05	0.00175	CbGpPWpGaD
Ketobemidone—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.04e-05	0.0017	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CCL20—ulcerative colitis	4.02e-05	0.00169	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCR1—ulcerative colitis	4.02e-05	0.00169	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CXCR2—ulcerative colitis	3.95e-05	0.00166	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—GHRL—ulcerative colitis	3.93e-05	0.00165	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	3.92e-05	0.00165	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CCL20—ulcerative colitis	3.89e-05	0.00164	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—ADRB2—ulcerative colitis	3.84e-05	0.00162	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—GNA12—ulcerative colitis	3.78e-05	0.00159	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CHP1—ulcerative colitis	3.75e-05	0.00158	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCR1—ulcerative colitis	3.74e-05	0.00157	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CCR6—ulcerative colitis	3.71e-05	0.00156	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—GNA12—ulcerative colitis	3.65e-05	0.00154	CbGpPWpGaD
Ketobemidone—OPRK1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	3.63e-05	0.00153	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CXCR2—ulcerative colitis	3.59e-05	0.00151	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CCL20—ulcerative colitis	3.53e-05	0.00149	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.51e-05	0.00148	CbGpPWpGaD
Ketobemidone—OPRD1—G alpha (i) signalling events—CXCL8—ulcerative colitis	3.5e-05	0.00147	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CXCR2—ulcerative colitis	3.46e-05	0.00146	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCR1—ulcerative colitis	3.4e-05	0.00143	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CCR6—ulcerative colitis	3.37e-05	0.00142	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—GNA12—ulcerative colitis	3.32e-05	0.0014	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	3.3e-05	0.00139	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SEL1L—ulcerative colitis	3.29e-05	0.00138	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CCL20—ulcerative colitis	3.28e-05	0.00138	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—PTGER4—ulcerative colitis	3.27e-05	0.00138	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CCR6—ulcerative colitis	3.26e-05	0.00137	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—ADRB2—ulcerative colitis	3.25e-05	0.00137	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—DLD—ulcerative colitis	3.24e-05	0.00136	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCR2—ulcerative colitis	3.14e-05	0.00132	CbGpPWpGaD
Ketobemidone—OPRM1—TCR Signaling Pathway—IL6—ulcerative colitis	3.14e-05	0.00132	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—GNA12—ulcerative colitis	3.09e-05	0.0013	CbGpPWpGaD
Ketobemidone—OPRM1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	3.07e-05	0.00129	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—CXCL8—ulcerative colitis	3.07e-05	0.00129	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CHP1—ulcerative colitis	3.06e-05	0.00129	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—GHRL—ulcerative colitis	2.99e-05	0.00126	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CCL20—ulcerative colitis	2.98e-05	0.00126	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PTGER4—ulcerative colitis	2.97e-05	0.00125	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CCR6—ulcerative colitis	2.96e-05	0.00124	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCR2—ulcerative colitis	2.93e-05	0.00123	CbGpPWpGaD
Ketobemidone—UGT1A9—NRF2 pathway—TGFB1—ulcerative colitis	2.89e-05	0.00122	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SEL1L—ulcerative colitis	2.88e-05	0.00121	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PTGER4—ulcerative colitis	2.87e-05	0.00121	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—GNA12—ulcerative colitis	2.8e-05	0.00118	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.78e-05	0.00117	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CCR6—ulcerative colitis	2.75e-05	0.00116	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—GHRL—ulcerative colitis	2.72e-05	0.00114	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCR1—ulcerative colitis	2.71e-05	0.00114	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	2.66e-05	0.00112	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCR2—ulcerative colitis	2.66e-05	0.00112	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—DLD—ulcerative colitis	2.64e-05	0.00111	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CALM3—ulcerative colitis	2.63e-05	0.00111	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—GHRL—ulcerative colitis	2.62e-05	0.00111	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PTGER4—ulcerative colitis	2.6e-05	0.0011	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—CXCL8—ulcerative colitis	2.59e-05	0.00109	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	2.59e-05	0.00109	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CCR6—ulcerative colitis	2.5e-05	0.00105	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—ADRB2—ulcerative colitis	2.48e-05	0.00104	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.44e-05	0.00103	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SEL1L—ulcerative colitis	2.44e-05	0.00103	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PTGER4—ulcerative colitis	2.42e-05	0.00102	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—GHRL—ulcerative colitis	2.38e-05	0.001	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCL20—ulcerative colitis	2.38e-05	0.001	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCR1—ulcerative colitis	2.37e-05	0.001	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CHP1—ulcerative colitis	2.33e-05	0.000982	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CALM3—ulcerative colitis	2.31e-05	0.000972	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—ADRB2—ulcerative colitis	2.25e-05	0.000947	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GNA12—ulcerative colitis	2.23e-05	0.000941	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—GHRL—ulcerative colitis	2.22e-05	0.000934	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PTGER4—ulcerative colitis	2.2e-05	0.000926	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—ADRB2—ulcerative colitis	2.17e-05	0.000915	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCR2—ulcerative colitis	2.12e-05	0.000892	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—CXCL8—ulcerative colitis	2.12e-05	0.000892	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—ADCY5—ulcerative colitis	2.1e-05	0.000885	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCL20—ulcerative colitis	2.08e-05	0.000878	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.06e-05	0.000868	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—GHRL—ulcerative colitis	2.01e-05	0.000848	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—DLD—ulcerative colitis	2.01e-05	0.000848	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCR1—ulcerative colitis	2.01e-05	0.000845	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCR6—ulcerative colitis	1.99e-05	0.000839	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CHP1—ulcerative colitis	1.98e-05	0.000832	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—ADRB2—ulcerative colitis	1.97e-05	0.000831	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GNA12—ulcerative colitis	1.96e-05	0.000825	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CALM3—ulcerative colitis	1.95e-05	0.000821	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—ADCY5—ulcerative colitis	1.91e-05	0.000804	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MAML2—ulcerative colitis	1.89e-05	0.000795	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCR2—ulcerative colitis	1.86e-05	0.000782	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—CXCL8—ulcerative colitis	1.86e-05	0.000782	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.85e-05	0.000779	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.84e-05	0.000776	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	1.84e-05	0.000773	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CHP1—ulcerative colitis	1.76e-05	0.000742	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCL20—ulcerative colitis	1.76e-05	0.000742	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTGER4—ulcerative colitis	1.75e-05	0.000738	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCR6—ulcerative colitis	1.75e-05	0.000735	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.71e-05	0.000721	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—DLD—ulcerative colitis	1.71e-05	0.000718	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—ADCY5—ulcerative colitis	1.67e-05	0.000705	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—ADRB2—ulcerative colitis	1.67e-05	0.000702	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GNA12—ulcerative colitis	1.66e-05	0.000697	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MAML2—ulcerative colitis	1.66e-05	0.000697	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.65e-05	0.000696	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.61e-05	0.000677	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—GHRL—ulcerative colitis	1.61e-05	0.000676	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCR2—ulcerative colitis	1.57e-05	0.000661	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—CXCL8—ulcerative colitis	1.57e-05	0.000661	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTGS1—ulcerative colitis	1.57e-05	0.000659	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.56e-05	0.000656	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CALM3—ulcerative colitis	1.56e-05	0.000655	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.54e-05	0.000648	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTGER4—ulcerative colitis	1.54e-05	0.000647	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RIPK2—ulcerative colitis	1.53e-05	0.000645	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—DLD—ulcerative colitis	1.52e-05	0.000641	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.51e-05	0.000634	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCR6—ulcerative colitis	1.48e-05	0.000622	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—ADCY5—ulcerative colitis	1.42e-05	0.000596	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CALM3—ulcerative colitis	1.41e-05	0.000593	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—GHRL—ulcerative colitis	1.41e-05	0.000593	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MAML2—ulcerative colitis	1.4e-05	0.000589	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.4e-05	0.000588	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—DLD—ulcerative colitis	1.39e-05	0.000584	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CALM3—ulcerative colitis	1.36e-05	0.000574	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.35e-05	0.000567	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RIPK2—ulcerative colitis	1.34e-05	0.000566	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ADRB2—ulcerative colitis	1.33e-05	0.00056	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—JAK2—ulcerative colitis	1.31e-05	0.000552	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTGER4—ulcerative colitis	1.3e-05	0.000547	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.26e-05	0.000528	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.2e-05	0.000504	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—JAK2—ulcerative colitis	1.19e-05	0.000501	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GHRL—ulcerative colitis	1.19e-05	0.000501	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ADRB2—ulcerative colitis	1.17e-05	0.000491	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CALM3—ulcerative colitis	1.15e-05	0.000485	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—JAK2—ulcerative colitis	1.15e-05	0.000484	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CALM3—ulcerative colitis	1.15e-05	0.000484	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—IL2—ulcerative colitis	1.14e-05	0.000481	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RIPK2—ulcerative colitis	1.14e-05	0.000478	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ADCY5—ulcerative colitis	1.13e-05	0.000475	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.1e-05	0.000462	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ABCB1—ulcerative colitis	1.1e-05	0.000461	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CXCL8—ulcerative colitis	1.09e-05	0.000458	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.06e-05	0.000446	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.05e-05	0.000442	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—JAK2—ulcerative colitis	1.04e-05	0.00044	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL2—ulcerative colitis	1.04e-05	0.000437	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ADCY5—ulcerative colitis	1.02e-05	0.000431	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—IL2—ulcerative colitis	1e-05	0.000422	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ADCY5—ulcerative colitis	9.89e-06	0.000417	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ADRB2—ulcerative colitis	9.85e-06	0.000415	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS1—ulcerative colitis	9.74e-06	0.00041	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—JAK2—ulcerative colitis	9.72e-06	0.000409	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCL8—ulcerative colitis	9.53e-06	0.000401	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—DLD—ulcerative colitis	9.15e-06	0.000385	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL2—ulcerative colitis	9.11e-06	0.000383	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	9.02e-06	0.00038	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ABCB1—ulcerative colitis	8.94e-06	0.000376	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	8.87e-06	0.000373	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—JAK2—ulcerative colitis	8.82e-06	0.000371	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CALM3—ulcerative colitis	8.77e-06	0.000369	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—IL2—ulcerative colitis	8.47e-06	0.000357	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ADCY5—ulcerative colitis	8.36e-06	0.000352	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ADCY5—ulcerative colitis	8.34e-06	0.000351	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS1—ulcerative colitis	8.24e-06	0.000347	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.11e-06	0.000341	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCL8—ulcerative colitis	8.05e-06	0.000339	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.05e-06	0.000339	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL2—ulcerative colitis	7.7e-06	0.000324	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PPARG—ulcerative colitis	7.63e-06	0.000321	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CALM3—ulcerative colitis	7.42e-06	0.000312	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS1—ulcerative colitis	7.36e-06	0.00031	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.34e-06	0.000309	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.24e-06	0.000305	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.09e-06	0.000299	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—JAK2—ulcerative colitis	7.03e-06	0.000296	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ALB—ulcerative colitis	6.86e-06	0.000289	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ABCB1—ulcerative colitis	6.82e-06	0.000287	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RELA—ulcerative colitis	6.81e-06	0.000287	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS1—ulcerative colitis	6.71e-06	0.000282	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CALM3—ulcerative colitis	6.62e-06	0.000279	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.6e-06	0.000278	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCL8—ulcerative colitis	6.42e-06	0.00027	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ADCY5—ulcerative colitis	6.36e-06	0.000268	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.33e-06	0.000267	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPARG—ulcerative colitis	6.22e-06	0.000262	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—JAK2—ulcerative colitis	6.17e-06	0.00026	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL2—ulcerative colitis	6.13e-06	0.000258	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL6—ulcerative colitis	6.1e-06	0.000257	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CALM3—ulcerative colitis	6.04e-06	0.000254	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTGS2—ulcerative colitis	6e-06	0.000253	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RELA—ulcerative colitis	5.97e-06	0.000251	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MMP9—ulcerative colitis	5.81e-06	0.000244	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.77e-06	0.000243	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ABCB1—ulcerative colitis	5.77e-06	0.000243	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NFKB1—ulcerative colitis	5.74e-06	0.000242	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCL8—ulcerative colitis	5.63e-06	0.000237	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ALB—ulcerative colitis	5.59e-06	0.000235	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ADCY5—ulcerative colitis	5.38e-06	0.000227	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL2—ulcerative colitis	5.38e-06	0.000226	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL6—ulcerative colitis	5.35e-06	0.000225	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—JAK2—ulcerative colitis	5.21e-06	0.000219	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STAT3—ulcerative colitis	5.16e-06	0.000217	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ABCB1—ulcerative colitis	5.15e-06	0.000217	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MMP9—ulcerative colitis	5.09e-06	0.000214	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RELA—ulcerative colitis	5.05e-06	0.000213	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NFKB1—ulcerative colitis	5.04e-06	0.000212	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTGS2—ulcerative colitis	4.89e-06	0.000206	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ADCY5—ulcerative colitis	4.81e-06	0.000202	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TGFB1—ulcerative colitis	4.79e-06	0.000201	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCL8—ulcerative colitis	4.76e-06	0.0002	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARG—ulcerative colitis	4.74e-06	0.0002	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ABCB1—ulcerative colitis	4.7e-06	0.000198	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL2—ulcerative colitis	4.55e-06	0.000191	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STAT3—ulcerative colitis	4.53e-06	0.000191	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL6—ulcerative colitis	4.52e-06	0.00019	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS1—ulcerative colitis	4.42e-06	0.000186	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ADCY5—ulcerative colitis	4.38e-06	0.000184	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MMP9—ulcerative colitis	4.3e-06	0.000181	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ALB—ulcerative colitis	4.26e-06	0.00018	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NFKB1—ulcerative colitis	4.26e-06	0.000179	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TGFB1—ulcerative colitis	4.2e-06	0.000177	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARG—ulcerative colitis	4.02e-06	0.000169	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.98e-06	0.000168	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—ulcerative colitis	3.94e-06	0.000166	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STAT3—ulcerative colitis	3.83e-06	0.000161	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS2—ulcerative colitis	3.73e-06	0.000157	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ALB—ulcerative colitis	3.61e-06	0.000152	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL6—ulcerative colitis	3.61e-06	0.000152	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARG—ulcerative colitis	3.58e-06	0.000151	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TGFB1—ulcerative colitis	3.55e-06	0.000149	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—ulcerative colitis	3.45e-06	0.000145	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARG—ulcerative colitis	3.27e-06	0.000138	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ALB—ulcerative colitis	3.22e-06	0.000136	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL6—ulcerative colitis	3.16e-06	0.000133	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS2—ulcerative colitis	3.16e-06	0.000133	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ABCB1—ulcerative colitis	3.1e-06	0.00013	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ALB—ulcerative colitis	2.94e-06	0.000124	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—ulcerative colitis	2.92e-06	0.000123	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.89e-06	0.000122	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS2—ulcerative colitis	2.82e-06	0.000119	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6—ulcerative colitis	2.67e-06	0.000113	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.57e-06	0.000108	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.16e-06	9.07e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALB—ulcerative colitis	1.94e-06	8.16e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.7e-06	7.14e-05	CbGpPWpGaD
